Ambulatory cervical ripening in term pregnancy

Nirmala Upadhyaya, Kent D. Childs, Ran Neiger, Michael Caudle

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVE: To study the safe use of Dilapan at term for ripening the unfavorable cervix in an outpatient setting. STUDY DESIGN: Prospective review of cervical ripening with Dilapan in women at term gestation. Such women were assigned to either outpatient or inpatient cervical ripening with Dilapan. RESULTS: Twenty-one patients were assigned to each group. The length of induction was similar between women who had ambulatory cervical ripening and hospitalized patients (11 ± 7 vs. 14 ± 7 hours, respectively), and the rates of chorioamnionitis, endometritis and nonreassuring fetal heart rate tracings were also similar. However, the average length of hospitalization was significantly shorter for those who had ambulatory ripening as compared to those who were hospitalized (51 ± 27 vs. 70 ± 20 hours, respectively; P < .0007). CONCLUSION: The use of Dilapan for cervical ripening at term in an ambulatory setting is safe and effective and may decrease the overall hospitalization time and cost. (J Reprod Med 1999;44:363-366).

Original languageEnglish (US)
Pages (from-to)363-366
Number of pages4
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume44
Issue number4
StatePublished - Apr 1 1999
Externally publishedYes

Fingerprint

Cervical Ripening
Pregnancy
Hospitalization
Outpatients
Chorioamnionitis
Endometritis
Fetal Heart Rate
Cervix Uteri
Inpatients
Costs and Cost Analysis
dilapan

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Ambulatory cervical ripening in term pregnancy. / Upadhyaya, Nirmala; Childs, Kent D.; Neiger, Ran; Caudle, Michael.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 44, No. 4, 01.04.1999, p. 363-366.

Research output: Contribution to journalArticle

@article{a6342a31566a4f59bf3b3de6308617f5,
title = "Ambulatory cervical ripening in term pregnancy",
abstract = "OBJECTIVE: To study the safe use of Dilapan at term for ripening the unfavorable cervix in an outpatient setting. STUDY DESIGN: Prospective review of cervical ripening with Dilapan in women at term gestation. Such women were assigned to either outpatient or inpatient cervical ripening with Dilapan. RESULTS: Twenty-one patients were assigned to each group. The length of induction was similar between women who had ambulatory cervical ripening and hospitalized patients (11 ± 7 vs. 14 ± 7 hours, respectively), and the rates of chorioamnionitis, endometritis and nonreassuring fetal heart rate tracings were also similar. However, the average length of hospitalization was significantly shorter for those who had ambulatory ripening as compared to those who were hospitalized (51 ± 27 vs. 70 ± 20 hours, respectively; P < .0007). CONCLUSION: The use of Dilapan for cervical ripening at term in an ambulatory setting is safe and effective and may decrease the overall hospitalization time and cost. (J Reprod Med 1999;44:363-366).",
author = "Nirmala Upadhyaya and Childs, {Kent D.} and Ran Neiger and Michael Caudle",
year = "1999",
month = "4",
day = "1",
language = "English (US)",
volume = "44",
pages = "363--366",
journal = "The Journal of reproductive medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "4",

}

TY - JOUR

T1 - Ambulatory cervical ripening in term pregnancy

AU - Upadhyaya, Nirmala

AU - Childs, Kent D.

AU - Neiger, Ran

AU - Caudle, Michael

PY - 1999/4/1

Y1 - 1999/4/1

N2 - OBJECTIVE: To study the safe use of Dilapan at term for ripening the unfavorable cervix in an outpatient setting. STUDY DESIGN: Prospective review of cervical ripening with Dilapan in women at term gestation. Such women were assigned to either outpatient or inpatient cervical ripening with Dilapan. RESULTS: Twenty-one patients were assigned to each group. The length of induction was similar between women who had ambulatory cervical ripening and hospitalized patients (11 ± 7 vs. 14 ± 7 hours, respectively), and the rates of chorioamnionitis, endometritis and nonreassuring fetal heart rate tracings were also similar. However, the average length of hospitalization was significantly shorter for those who had ambulatory ripening as compared to those who were hospitalized (51 ± 27 vs. 70 ± 20 hours, respectively; P < .0007). CONCLUSION: The use of Dilapan for cervical ripening at term in an ambulatory setting is safe and effective and may decrease the overall hospitalization time and cost. (J Reprod Med 1999;44:363-366).

AB - OBJECTIVE: To study the safe use of Dilapan at term for ripening the unfavorable cervix in an outpatient setting. STUDY DESIGN: Prospective review of cervical ripening with Dilapan in women at term gestation. Such women were assigned to either outpatient or inpatient cervical ripening with Dilapan. RESULTS: Twenty-one patients were assigned to each group. The length of induction was similar between women who had ambulatory cervical ripening and hospitalized patients (11 ± 7 vs. 14 ± 7 hours, respectively), and the rates of chorioamnionitis, endometritis and nonreassuring fetal heart rate tracings were also similar. However, the average length of hospitalization was significantly shorter for those who had ambulatory ripening as compared to those who were hospitalized (51 ± 27 vs. 70 ± 20 hours, respectively; P < .0007). CONCLUSION: The use of Dilapan for cervical ripening at term in an ambulatory setting is safe and effective and may decrease the overall hospitalization time and cost. (J Reprod Med 1999;44:363-366).

UR - http://www.scopus.com/inward/record.url?scp=0040882925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0040882925&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 363

EP - 366

JO - The Journal of reproductive medicine

JF - The Journal of reproductive medicine

SN - 0024-7758

IS - 4

ER -